A Look Inside the Pendulum Partners Program

What is Pendulum Glucose Control (PGC)? Pendulum Glucose Control provides a targeted approach to Type 2 diabetes care. Pendulum Glucose Control (PGC) is a synbiotic with a proprietary blend with five anaerobic microbe probiotics and the prebiotic inulin. The five strains in PGC are known to be missing or lacking functionality in people with Type 2 diabetes. Here’s a look at what’s inside PGC: Why Do Specific Strains Matter? Akkermansia Muciniphila: Microbe...

Continue reading
Meet Pendulum’s Senior Scientist, Maggie Stoeva, Ph.D.

  Maggie Stoeva is a senior scientist on the Molecular Team at Pendulum. Maggie received her Ph.D. in Microbiology at the University of California, Berkeley, in the Coates laboratory of applied and environmental microbiology. Maggie's research focused on sulfate-reducing microbes: ubiquitous, anaerobic “bugs” with economic, environmental and human-health consequences. She also investigated how sulfate-reducers cope with stressors, such as inhibitory compounds, both on an ecological and molecular scale, and uncovered novel cellular...

Continue reading
Pendulum Therapeutics Launches First Medical Probiotic For People With Type 2 Diabetes

SAN FRANCISCO, June 4, 2020 /PRNewswire/ -- Pendulum Therapeutics, a cutting-edge microbiome company dedicated to making people healthier through microbiome-targeted solutions, announced today the launch of Pendulum Glucose Control, the first and only medical probiotic clinically shown to lower A1C and blood sugar spikes in individuals with T2D taking metformin. Pendulum Glucose Control is designed specifically for the dietary management of Type 2 diabetes, a condition affecting nearly 30 million Americans[1]. The management of...

Continue reading